Day At The Track

EPO POSITIVE FOR BRETT ROBINSON

11:05 PM 30 Aug 2007 NZST
Comment (...) Tweet Share Email Print
Brett Robinson
Brett Robinson - New Image Media

As a result of increased medication control efforts and an expanding program of out-of-competition testing, the licence of Brett Robinson has been suspended, following confirmation that the prohibited substance erythropoetin/darbepoetin-alfa was found in one of his race horses.

On August 30, 2007, the Director ordered the immediate suspension of the licence of standardbred driver/trainer/owner/authorized agent Brett Robinson of Caledonia, Ontario, and issued a proposed order to suspend his licence for a period of 10 years, and ordered a $40,000 fine.

The horse Fox Valley Tribal has been suspended from racing.

In July 2002, the Ontario Racing Commission (ORC) issued a rule prohibiting the possession and use of Erythropoetin – commonly known as EPO.

The ORC reminded all licensees in April of 2006 that severe penalties would be imposed on anyone found to have acquired, be in possession of, or have administered an EPO, such as Aranesp, to a horse.

Aranesp (darbepoetin-alfa) is classed as a potent long-lasting form of EPO and poses a very serious danger to the health and welfare of a horse.

As part of ongoing medication control efforts, in May 2006, the ORC issued a Directive requiring all owners or trainers to make their horses available for a blood test at any time without prior notice. In June of 2007 this Directive was expanded to include all biological samples.

The ORC recognizes that the health and well being of the horse is of paramount concern to the horse racing community, and that by far the majority of those licensed in the industry conducts their business with professionalism and abide by the rules.

Through its support of the industry-funded Equine Medication Control and Drug Task Force, that community is clearly behind the efforts of the ORC to reinforce the message that the acquisition, possession and administration of illegal and non-therapeutic drugs will not be tolerated.

The vigilant commitment to a program of out of competition testing based on change of performance and/or reasonable cause will continue, supported by new advancements in testing technology.

This pattern of testing, investigation, punishment and penalties also will continue. As stated numerous times in these Notices, the reputation of horse racing in Ontario and the financial stability of the industry are on the line.

Standardbred Canada

Comment (...) Tweet Share Email Print

Read More News About...

Stallion Name

Next article: